A detailed history of Northern Trust Corp transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 38,914 shares of IMMX stock, worth $61,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,914
Previous 38,914 -0.0%
Holding current value
$61,873
Previous $77,000 25.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$2.64 - $6.68 $38,375 - $97,100
14,536 Added 59.63%
38,914 $119,000
Q4 2023

Feb 13, 2024

BUY
$2.82 - $7.27 $68,745 - $177,228
24,378 New
24,378 $168,000
Q3 2022

Nov 14, 2022

BUY
$1.36 - $3.05 $26,045 - $58,410
19,151 New
19,151 $26,000

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $22.1M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.